Trial Profile
A Single dose, Open-Label, Randomized, 2-Way Crossover Bioequivalence Study of Ulipristal Acetate 30 mg Tablets Manufactured at LEON Farma (Spain) and Cardinal Health France (France) Under Fasted Conditions in Healthy Female Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy; Uterine leiomyoma
- Focus Pharmacokinetics
- Sponsors HRA Pharma
- 09 Feb 2010 New trial record